Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

AstraZeneca

Status: Completed

Conditions: Bronchial Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT01711840

D589LL00001

Details and patient eligibility

About

The purpose of the investigation is to confirm the safety of patients receiving Symbicort Turbuhaler as maintenance and reliever therapy ( Symbicort SMART) under the post-marketing actual use.

Full description

Symbicort Turbuhaler 30/60 Clinical Experience Investigation for treatment with Symbicort as maintenance therapy and as needed in response to symptoms

Enrollment: 2,409 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients receiving Symbicort Turbuhaler as maintenance and reliever therapy for the first time due to 'bronchial asthma ',and possibly requiring as-needed inhalations during the observation period

Trial design

2,409 participants in 1 patient group

Symbicort